2018 Section 6 - Laryngology, Voice Disorders, and Bronchoesophalogy

Otolaryngology–Head and Neck Surgery 155(6)

measurement affect statistical power? Quality Life Res . 2015; 24:273-277. 15. Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Quality Life Res . 2012;21:651-657. 16. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ . 2015; 349:g7647. 17. Francis DO, McPheeters ML, Noud M, Penson DF, Feurer ID. Checklist to operationalize measurement characteristics of patient-reported outcome measures. Syst Rev . In press. 18. Deary IJ, Wilson JA, Harris MB, MacDougall G. Globus phar- yngis: development of a symptom assessment scale. J Psychosom Res . 1995;39:203-213. 19. Papakonstantinou L, Leslie P, Gray J, Chadwick T, Hudson M, Wilson JA. Laryngopharyngeal reflux: a prospective analy- sis of a 34 item symptom questionnaire. Clin Otolaryngol . 2009;34:455-459. 20. Wilson JA, Deary IJ, Maran AG. The persistence of symptoms in patients with globus pharyngis. Clin Otolaryngol Allied Sci . 1991;16:202-205. 21. Belafsky PC, Postma GN, Koufman JA. Validity and reliabil- ity of the reflux symptom index (RSI). J Voice . 2002;16:274- 277. 22. Dauer E, Thompson D, Zinsmeister AR, et al. Supraesophageal reflux: validation of a symptom questionnaire. Otolaryngol Head Neck Surg . 2006;134:73-80. 23. Andersson O, Ryden A, Ruth M, Moller RY, Finizia C. Development and validation of a laryngopharyngeal reflux questionnaire, the Pharyngeal Reflux Symptom Questionnaire. Scand J Gastroenterol . 2010;45:147-159. 24. Carrau RL, Khidr A, Gold KF, et al. Validation of a quality- of-life instrument for laryngopharyngeal reflux. Arch Otolaryngol Head Neck Surg . 2005;131:315-320. 25. Rothman M, Farup C, Stewart W, Helbers L, Zeldis J. Symptoms associated with gastroesophageal reflux disease: development of a questionnaire for use in clinical trials. Dig Dis Sci . 2001;46:1540-1549. 26. Vaezi MF, Hicks DM, Abelson TI, Richter JE. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol . 2003;1:333-344. 27. Vaezi MF, Schroeder PL, Richter JE. Reproducibility of proxi- mal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol . 1997;92:825-829. 28. Shaker R, Bardan E, Gu C, Kern M, Torrico L, Toohill R. Intrapharyngeal distribution of gastric acid refluxate. Laryngoscope . 2003;113:1182-1191. 29. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status question- naires. J Clin Epidemiol . 2007;60:34-42. 30. Velicer WF, Fava JL. Effects of variable and subject sampling on factor pattern recovery. Psychol Methods . 1998;3:231-251. 31. Patel AK, Mildenhall NR, Kim W, Carroll TL. Symptom over- lap between laryngopharyngeal reflux and glottic insufficiency

approval of version to be published, and accountability for all aspects of the work; Michael F. Vaezi, conception and design, analysis, and interpretation of data, drafting of manuscript, criti- cally evaluating it for important intellectual content, final approval of version to be published, and accountability for all aspects of the work.

Disclosures Competing interests: None. Sponsorships: None.

Funding source: Funding provided by the National Institute on Deafness and Communication Disorders to D.O.F. (K23DC013559 and L30DC012687).

References

1. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology . 1997;112:1448-1456. 2. Hallewell JD, Cole TB. Isolated head and neck symptoms due to hiatus hernia. Arch Otolaryngol . 1970;92:499-501. 3. Chodosh PL. Gastro-esophago-pharyngeal reflux. Laryngoscope . 1977;87(9, pt 1):1418-1427. 4. Jacobs A. Post-cricoid carcinoma: regional incidence in England and Wales. Br Med J . 1963;2:1373-1375. 5. Delahunty JE, Cherry J. Experimentally produced vocal cord granulomas. Laryngoscope . 1968;78:1941-1947. 6. Cherry J, Margulies SI. Contact ulcer of the larynx. Laryngoscope . 1968;78:1937-1940. 7. Koufman JA. The otolaryngologic manifestations of gastroeso- phageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope . 1991;101(4, pt 2)(suppl 53):1-78. 8. Koufman JA. Laryngopharyngeal reflux is different from clas- sic gastroesophageal reflux disease. Ear Nose Throat J . 2002; 81(9)(suppl 2):7-9. 9. Francis DO, Rymer JA, Slaughter JC, et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol . 2013;108:905-911. 10. Milstein CF, Charbel S, Hicks DM, Abelson TI, Richter JE, Vaezi MF. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs flexible laryngoscope). Laryngoscope . 2005;115:2256-2261. 11. Qadeer MA, Swoger J, Milstein C, et al. Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux. Laryngoscope . 2005;115:1947-1952. 12. Powell J, Cocks HC. Mucosal changes in laryngopharyngeal reflux: prevalence, sensitivity, specificity and assessment. Laryngoscope . 2013;123:985-991. 13. Patrick DL, Burke LB, Powers JH, et al. Patient-reported out- comes to support medical product labeling claims: FDA per- spective. Value Health . 2007;10(suppl 2):S125-S137. 14. Regnault A, Hamel JF, Patrick DL. Pooling of cross-cultural PRO data in multinational clinical trials: how much can poor

206